Institutional shares held 362 Million
5.4M calls
4.3M puts
Total value of holdings $30.1B
$448M calls
$357M puts
Market Cap $32.8B
386,257,984 Shares Out.
Institutional ownership 93.84%
# of Institutions 1,083


Latest Institutional Activity in DXCM

Top Purchases

Q2 2025
Zevenbergen Capital Investments LLC Shares Held: 623K ($52.9M)
Q2 2025
Financiere Des Professionnels Fonds D,Investissement Inc. Shares Held: 16.4K ($1.39M)
Q2 2025
Swedbank Ab Shares Held: 234K ($19.8M)
Q2 2025
Mn Services Vermogensbeheer B.V. Shares Held: 147K ($12.4M)
Q2 2025
Czech National Bank Shares Held: 95.8K ($8.13M)

Top Sells

Q2 2025
Gradient Investments LLC Shares Held: 270K ($22.9M)
Q2 2025
Harbor Investment Advisory, LLC Shares Held: 1.19K ($101K)
Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 35.8K ($3.03M)
Q2 2025
Exchange Traded Concepts, LLC Shares Held: 8.76K ($743K)
Q2 2025
Gk Wealth Management LLC Shares Held: 3.01K ($256K)

About DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.


Insider Transactions at DXCM

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
530K Shares
From 21 Insiders
Grant, award, or other acquisition 514K shares
Bona fide gift 16.1K shares
Sell / Disposition
190K Shares
From 15 Insiders
Open market or private sale 174K shares
Bona fide gift 16.1K shares

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM